Vivotif (PaxVax Berna GmbH)


Welcome to the PulseAid listing for the Vivotif drug offered from PaxVax Berna GmbH. This Live Attenuated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Typhoid [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: PaxVax Berna GmbH
NON-PROPRIETARY NAME: Salmonella typhi Ty21a
SUBSTANCE NAME: SALMONELLA TYPHI TY21A LIVE ANTIGEN
TYPE: VACCINE
PHARMA CLASS: Live Attenuated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Typhoid [Chemical/Ingredient],Vaccines, Attenuated [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, COATED
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1992-03-16
END MARKETING DATE: 0000-00-00


Vivotif VACCINE Details:

Item DescriptionVivotif from PaxVax Berna GmbH
LABELER NAME: PaxVax Berna GmbH
DEA SCHEDULE:
ACTIVE STRENGTH: 6000000000([CFU]/1)
START MARKETING DATE: 1992-03-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69401-000_59d35789-5090-4b92-bbbd-50dd38885d9c
PRODUCT NDC: 69401-000
APPLICATION NUMBER: BLA103123

Other SALMONELLA TYPHI TY21A LIVE ANTIGEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PaxVax Berna GmbHVivotif